A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1435
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : AmB
Long Form : amphotericin B
No. Year Title Co-occurring Abbreviation
2019 A Facile Synthesis of Alkaline Electrolyte Based Graphene Sheets, Their Functionalization and Attachment of Some Drugs. GS, TMX
2019 A Functional Wound Dressing as a Potential Treatment for Cutaneous Leishmaniasis. CL, PVA, PVA-AmB
2019 Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations. DSC, FT-IR, HSM, NLCs, PXRD, SLNs
2019 Amphotericin B-Loaded Emulgel: Effect of Chemical Enhancers on the Release Profile and Antileishmanial Activity In Vitro. ---
2019 Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis. CL, NPs, PLGA
2019 Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo. ROS
2019 Capillary electrophoresis with preparative isoelectric focusing preconcentration for sensitive determination of amphotericin B inhuman blood serum. CIEF, CZE, IEF
2019 Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods. EA
2019 Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy. BSA
10  2019 Effect of amphotericin B and voriconazole on the outgrowth of conidia of Aspergillus fumigatus followed by time-lapse microscopy. VRC
11  2019 ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait. RS
12  2019 Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa. ACTA, FLU
13  2019 In vitro activity of amphotericin B-azole combinations against Malassezia pachydermatis strains. FICI, ITC, VRC
14  2019 In vitro activity of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Trichosporon asahii. CAS, DPDS, Ebs, FCZ, FS, ITZ, MIC
15  2019 In vitro activity of voriconazole and amphotericin B against Candida albicans, Candida krusei, and Cryptococcus neoformans in human cerebrospinal fluid. CNS, CSF, SDB, VOR
16  2019 In Vitro Interactions of Amphotericin B Combined with Non-antifungal Agents Against Rhodotorula mucilaginosa Strains. ---
17  2019 In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic F127-based polymeric micelle system against Leishmania amazonensis infection. ---
18  2019 In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent ofinvasive aspergillosis. 5-FC, AFG, CAS, ISA, ITC, LAN, LUL, MEC, MIC, POS, VRC
19  2019 Isolation of Aspergillus caninus (Synonym: Phialosimplex caninus) from a Canine Iliac Lymph node. FLZ, ITZ, MCF, VRZ
20  2019 Local delivery polymer provides sustained antifungal activity of amphotericin B with reduced cytotoxicity. pCD
21  2019 Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance. AFST, WGS
22  2019 Nanocapsules of Sterculia striata acetylated polysaccharide as a potential monomeric amphotericin B delivery matrix. ASSP, DS, NC, PDI
23  2019 Noncovalent Complexation of Amphotericin B with Poly(beta-Amino Ester) Derivates for Treatment of C. Neoformans Infection. MPEG-PLA-PAE
24  2019 Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data. ECVs, ITS, MICs, non-WT, SYO
25  2019 Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres. AST
26  2019 Synergistic Antifungal Activity of Isoquercitrin: Apoptosis and Membrane Permeabilization Related to Reactive Oxygen Species in Candida albicans. FLC, ISO, ROS
27  2019 Synergistic Antifungal Effect of Amphotericin B-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles and Ultrasound against Candida albicans Biofilms. CLSM, PLGA, SEM
28  2019 Synthesis and characterization of NH2-(AEEA)n-amphotericin B derivatives. ---
29  2019 The Effects of Mentha piperita Essential Oil on C. albicans Growth, Transition, Biofilm Formation, and the Expression of Secreted Aspartyl Proteinases Genes. EO, EOs, HWP1
30  2019 The Perpendicular Orientation of Amphotericin B Methyl Ester in Hydrated Lipid Bilayers Supports the Barrel-Stave Model. NMR
31  2018 3-Bromopyruvate as an Alternative Option for the Treatment of Protothecosis. 3-BP, MAC, MIC
32  2018 A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing. CSF, NGS, PAM
33  2018 A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B. C-AmB, EE, NE, VL
34  2018 A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia. ---
35  2018 A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil. CAS, ECVs, FLU, HIV, ITR, MICs, VCZ
36  2018 Acyclic peptides incorporating the d-Phe-2-Abz turn motif: Investigations on antimicrobial activity and propensity to adopt beta-hairpin conformations. MICs, ROE
37  2018 Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system. FLC, PLGA
38  2018 Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies. CI, RCTs
39  2018 Amphotericin B-albumin conjugates: Synthesis, toxicity and anti-fungal activity. BSA, HSA, MIC
40  2018 Amphotericin B-conjugated polypeptide hydrogels as a novel innovative strategy for fungal infections. DEX, NPX
41  2018 Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations. NLCs, SLN, SLNs
42  2018 Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B. PLGA
43  2018 Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study. AAc, Trag
44  2018 Antifungal Susceptibility, Morphological and Molecular Characterization of Lasiodiplodia theobromae Isolated from a Patient with Keratitis. FLC, ITC, ITS, VRC
45  2018 Aspergillus terreus: Novel lessons learned on amphotericin B resistance. HSP
46  2018 Assessment of the mutagenic, recombinogenic, and carcinogenic potential of amphotericin B in somatic cells of Drosophila melanogaster. HB, SMART
47  2018 Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier. SDCS
48  2018 Bioanalysis of free and liposomal Amphotericin B in rat plasma using solid phase extraction and protein precipitation followed by LC-MS/MS. F-AMB, L-AMB, T-AMB
49  2018 Biomolecular interactions of amphotericin B nanomicelles with serum albumins: A combined biophysical and molecular docking approach. BSA, HSA
50  2018 Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity. AmB-D, BSA
51  2018 Candida lusitaniae - a case report of an intraperitoneal infection. ---
52  2018 Chitosan functionalized poly (epsilon-caprolactone) nanoparticles for amphotericin B delivery. PDI
53  2018 Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs. ---
54  2018 Combination of Posaconazole and Amphotericin B in the Treatment of Candida glabrata Biofilms. CFU, FICI, MBEC, MFC, MIC, PCZ
55  2018 Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis. CL
56  2018 Comparative studies on amphotericin B nanosuspensions prepared by a high pressure homogenization method and an antisolvent precipitation method. AmB-HPH
57  2018 Comparison of conventional and lipid emulsion formulations of amphotericin B: Pharmacokinetics and toxicokinetics in dogs. ---
58  2018 Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico. allo-HSCT, ICERs, IFIs, MXN
59  2018 Dermaseptin-S1 decreases Candida albicans growth, biofilm formation and the expression of hyphal wall protein 1 and aspartic protease genes. DS1
60  2018 Design of mannosylated oral amphotericin B nanoformulation: efficacy and safety in visceral leishmaniasis. MTC, NCs, PI
61  2018 Development and anti-Candida evaluation of the vaginal delivery system of amphotericin B nanosuspension-loaded thermogel. VVC
62  2018 Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism. AMD, CAS, Dox, ITR, MFX, VRC
63  2018 Does the use of antifungal agents in agriculture and food foster polyene resistance development? A reason for concern. ---
64  2018 Dual alginate-lipid nanocarriers as oral delivery systems for amphotericin B. NLC
65  2018 Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis. FICI, FLU, ITC, MIC
66  2018 Efficacy of nasal irrigation with 200 mug/mL amphotericin B after functional endoscopic sinus surgery: a randomized, placebo-controlled, double-blind study. CRS, FESS, TWSNOT-22
67  2018 Efficacy of novel Schiff base derivatives as antifungal compounds in combination with approved drugs against Candida albicans. FICI, FLC
68  2018 Emulgel based on amphotericin B and bacuri butter (Platonia insignis Mart.) for the treatment of cutaneous leishmaniasis: characterization and in vitro assays. IS
69  2018 Evaluating drug resistance in visceral leishmaniasis: the challenges. MIL, VL
70  2018 Fungal persister cells: The basis for recalcitrant infections? ROS
71  2018 Getting the Jump on the Development of Bullfrog Oil Microemulsions: a Nanocarrier for Amphotericin B Intended for Antifungal Treatment. MIC, PTPD
72  2018 In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis. Ab, CM
73  2018 In Vitro Antifungal Susceptibility of Candida Species Isolated from Iranian Patients with Denture Stomatitis. AFST, CADS, CAS, FLC, ITC, KET, MIC, PCR-RFLP, POS, TRB, VRC
74  2018 In-Vitro Activity of Silybin and Related Flavonolignans against Leishmania infantum and L. donovani. LD, Li, VL
75  2018 In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion. VL
76  2018 Insights into the candidacidal mechanism of Ctn[15-34] - a carboxyl-terminal, crotalicidin-derived peptide related to cathelicidins. 4N3OBA
77  2018 Intraspecies differences in natural susceptibility to amphotericine B of clinical isolates of Leishmania subgenus Viannia. ---
78  2018 Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions. AT, GLU, MA, MCL, MIL
79  2018 Investigation and simulation of dissolution with concurrent degradation under healthy and hypoalbuminaemic simulated parenteral conditions- case example Amphotericin B. BSA
80  2018 Invitro susceptibilities of Neoscytalidium spp. sequence types to antifungal agents and antimicrobial photodynamic treatment with phenothiazinium photosensitizers. 5-FC, aPDT, CAS, FLU, KET, MB, MIC, MLST, NMBN, PS, ST, TBO, TER, VOR
81  2018 Lyotropic Liquid Crystalline Nanoparticles of Amphotericin B: Implication of Phytantriol and Glyceryl Monooleate on Bioavailability Enhancement. GMO, LCNPs, PT
82  2018 Mode of action and synergistic effect of valinomycin and cereulide with amphotericin B against Candida albicans and Cryptococcus albidus. MFC, MIC
83  2018 Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil. CAS, CBM, FLC, ITC, ITS, KTC, MFG, MIC, POS, RVC, TRB, VRC
84  2018 Molecular Identification, Antifungal Susceptibility, and Geographic Origin of Clinical Strains of Sporothrix schenckii Complex in Mexico. ANF, CSF, FLC, ITC, MCF, PSC, TRB, VRC
85  2018 Molecular Umbrellas Modulate the Selective Toxicity of Polyene Macrolide Antifungals. NYS
86  2018 Mucormycosis in Iran: A six-year retrospective experience. ---
87  2018 Mucosal leishmaniasis: the experience of a Brazilian referral center. ML
88  2018 Neuroinfections caused by fungi. CSF, FIs-CNS
89  2018 Pickering emulsion stabilized by cashew gum- poly-l-lactide copolymer nanoparticles: Synthesis, characterization and amphotericin B encapsulation. PE
90  2018 Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents. ---
91  2018 Poor in vivo efficacy of caspofungin, micafungin and amphotericin B against wild-type Candida krusei clinical isolates does not correlate with in vitro susceptibility results. ---
92  2018 Portrait of Matrix Gene Expression in Candida glabrata Biofilms with Stress Induced by Different Drugs. Csf, FLU, Mcf
93  2018 Preparation and Characterization of Spherical Amorphous Solid Dispersion with Amphotericin B. DSC, FT-IR, SEM
94  2018 Preparation and In vitro Evaluation of Efficacy and Toxicity of Polysorbate 80-coated Bovine Serum Albumin Nanoparticles containing Amphotericin B. BSA, PS80
95  2018 Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: In vitro and in silico studies. KET, MA
96  2018 Reducing the toxicity of amphotericin B by encapsulation using methoxy poly(ethylene glycol)-b-poly(l-glutamic acid-co-l-phenylalanine). MTD
97  2018 Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis. CL, i.v
98  2018 Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis. CL
99  2018 Silver Nanoparticles with High Loading Capacity of Amphotericin B: Characterization, Bactericidal and Antifungal Effects. AgNPs
100  2018 Synthesis and evaluation of anti-fungal activities of sodium alginate-amphotericin B conjugates. MW, SA